ProCHO® 4 Protein-free CHO Medium with 0.1% Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine, 1 L.
ProCHO® 4 Protein-free CHO Medium with 0.1% Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine, 1 L
ProCHO® 4 Protein-free CHO Medium with 0.1% Pluronic® F-68 and phenol red, without L-glutamine, hypoxanthine or thymidine, 1 L
PowerFeed® A Chemically Defined and Protein-free Liquid Medium, 1L
PowerFeed® A Chemically Defined, Protein-free Basal Powder, without ferric citrate, 50L
PowerFeed® A, CD , Protein free, Basal Powder without ferric citrate, 10L
PowerFeed® A Chemically Defined and Protein-free Powder, 10L
PowerFeed® Chemically Defined and Protein-free basal Powder without ferric citrate, 100L
ProCHO® 5 Protein-free CHO Medium Powder kit with HEPES and 0.1% Pluronic® F-68, without L-Glutamine, phenol red, hypoxanthine or thymidine, 500 L (NAO)
ProCHO® 5, protein free CHO medium, with HEPES and 0.1% Pluronic® F-68, without L-Glutamine, phenol red, hypoxanthine or thymidine, 10 L powder kit (NAO)
-
Instructions - UltraCHO™ MediumHow to use ProCHO medium
-
Instructions – ProCHO Liquid mediaInstructions for use of ProCHO Media
-
Instructions ProCHO powder kitsInstructions for use of ProCHO Powder kits
-
ProCHO® Protein Expression Media
-
BE02-056Q CHO Xtreme™ Feed CD - InstructionsBE02-056Q
-
4D-Nucleofector® Protocol for Molt-4Optimized 384-well Nucleofector® and 4D-Nucleofector® Protocol for Molt-4
-
Molt-4 Transfection Protocol - 4D-Nucleofector™ X-UnitInstructions of use for transfection of Molt-4 cells with the SF Cell Line 4D-Nucleofector™ X Kit
-
MOLT-4 Transfection Protocol - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of MOLT-4 cells with the Cell Line Nucleofector™ Kit L
-
NB-4 Transfection Protocol - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of NB-4 cells (DSMZ) with the Cell Line Nucleofector™ Kit V
-
MV-4-11 Transfection Protocol - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of MV-4-11 cells with the Cell Line Nucleofector™ Kit L